Surfactants for Respiratory Distress Syndrome in Preterm Infants

Non Inferiority Trial Investigating Surfactants Administered Via MIST

Recruiting Phase 4 Interventional Study
Respiratory Distress Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 48 Hours
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
262 (estimated)
Sponsor
Endeavor Health · Other
Who this trial is looking for

This trial is looking for preterm babies aged 28-35 weeks who are having trouble breathing. If eligible, they will receive either curosurf or infasurf treatment through a special technique called MIST.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a preterm infant born between 28 and 35 weeks of gestation.
  • I am less than 48 hours old.
  • I have been diagnosed with respiratory distress syndrome.
  • I am on NCPAP.
  • I require FiO2 of 0.30 or higher.

You may not be able to join if

  • I have a congenital anomaly.
  • I have an alternative cause for respiratory distress.
  • I require emergency intubation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
RESEARCH DESIGN Multicenter, randomized, controlled trial. RECRUITMENT Entry criteria Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome. Infants who are on NCPAP and FiO2 ≥0.30 will randomized to curosurf or infasurf via MIST. Exclusion criteria Infants will be excluded if there is a congenital anomaly or an alt…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome confirmed by a chest x-ray on nasal continuous positive airway pressure (NCPAP) and FiO2 ≥0.30 Exclusion Criteria: * Infants will be exclud…
Contacts

Matthew Derrick

18475702920

mderrick@northshore.org

CONTACT